Schizophrenia is a complex medical condition that may require switching from an oral option or between different long-acting injectable options during the patient treatment journey. These data further ...

Marvell Technology's data center switching is accelerating, with revenues set to surpass $300 million in fiscal 2026 and $500 ...

--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., today presented data informing clinical strategies for switching patients to UZEDY ®, an extended-release injectable ...

Chipmaker Marvell Technology Inc.’s stock moved higher today after the company announced plans to acquire the network interconnect startup XConn Technologies Holdings Inc. in a stock-and-cash deal ...

Extreme Networks this week unveiled a blueprint for migrating data center networks from the physical world to virtualization, and then ultimately to cloud computing. While not as comprehensive or ...

In the rapidly evolving landscape of European tech regulation, the Data Act introduces changes with the potential to reshape established market dynamics, presenting significant challenges and ...

The EU’s sweeping Data Act is now in force. In this part of our series highlighting the Data Act’s key issues, our Privacy, Cyber & Data Strategy Team breaks down ...

The majority of studies evaluating biosimilar-to-biosimilar switching were for rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and ankylosing spondylitis. With a growing pool of ...

Traditional approaches to data center networking cannot satisfy the scale, bandwidth, latency and cost points required for evolving data center software architectures. Fibre Channel and InfiniBand ...

WASHINGTON, DC - DECEMBER 15: Consumer Financial Protection Bureau Director Rohit Chopra testifies before the Senate Banking, Housing and Urban Affairs Committee in the Dirksen Senate Office Building ...

NEW YORK (Reuters) - Network equipment maker Cisco Systems Inc on Monday launched a new switching product aimed at large data centers, and forecast strong sales despite worries of a slowdown in U.S.